Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry

被引:30
作者
Moore, AV
Kirk, SM
Callister, SM
Mazurek, GH
Schell, RF
机构
[1] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Med Microbiol, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Immunol, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA
[5] Gundersen Lutheran Med Ctr, Infect Dis Sect, La Crosse, WI 54601 USA
[6] BioRad Labs, Hercules, CA 94547 USA
[7] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1128/JCM.37.3.479-483.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We showed previously that susceptibility testing for Mycobacterium tuberculosis labeled with fluorescein diacetate could be accomplished rapidly by using flow cytometry, However, safety was a major concern because mycobacteria were not killed prior to Bow cytometric analysis. In this study, we developed a biologically safe flow cytometric susceptibility test that depends on detection and enumeration of actively growing M, tuberculosis organisms in drug-free and antimycobacterial agent-containing medium. The susceptibilities of 17 clinical isolates of M. tuberculosis to ethambutol, isoniazid, and rifampin were tested by the agar proportion and flow cytometric methods. Subsequently, all flow cytometric susceptibility test samples were inactivated by exposure to paraformaldehyde before analysis with a flow cytometer. Agreement between the results from the two methods was 98%. In addition, the flow cytometric results were available 72 h after the initiation of testing. The flow cytometric susceptibility assay is safe, simple to perform, and more rapid than conventional test methods, such as the BACTEC system and the proportion method.
引用
收藏
页码:479 / 483
页数:5
相关论文
共 15 条
[1]   NATIONWIDE SURVEY OF DRUG-RESISTANT TUBERCULOSIS IN THE UNITED-STATES [J].
BLOCH, AB ;
CAUTHEN, GM ;
ONORATO, IM ;
DANSBURY, KG ;
KELLY, GD ;
DRIVER, CR ;
SNIDER, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :665-671
[2]  
CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565
[3]  
Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P365
[4]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[5]   Estimation of the annual risk of tuberculous infection for white men in the United States [J].
Daniel, TM ;
Debanne, SM .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1535-1537
[6]  
HEIFETS LB, 1985, ANTIMICROB AGENTS CH, V27, P11, DOI 10.1128/AAC.27.1.11
[7]   Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours [J].
Kirk, SM ;
Schell, RF ;
Moore, AV ;
Callister, SM ;
Mazurek, GH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (06) :1568-1573
[8]   DETERMINATION OF MINIMAL INHIBITORY CONCENTRATIONS OF ANTITUBERCULOSIS DRUGS BY RADIOMETRIC AND CONVENTIONAL METHODS [J].
LEE, CN ;
HEIFETS, LB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (02) :349-352
[9]  
National Committee for Clinical Laboratory Standards, 1995, M24T NAT COMM CLIN L
[10]   RAPID SUSCEPTIBILITY TESTING OF MYCOBACTERIUM-TUBERCULOSIS (H37RA) BY FLOW-CYTOMETRY [J].
NORDEN, MA ;
KURZYNSKI, TA ;
BOWNDS, SE ;
CALLISTER, SM ;
SCHELL, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1231-1237